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Ethanol is known to cause both tolerance and sensiti-
zation to endotoxin (lipopolysaccharide). It is also
known that ethanol modulates the expression and activ-
ity of several intracellular signaling molecules and tran-
scription factors in monocytes and Kupffer cells, the
resident hepatic macrophages. Expression of CD14, the
endotoxin receptor, is up-regulated following chronic
exposure to endotoxin and ethanol. Ethanol-induced ox-
idative stress is important in the regulation of transcrip-
tion factor activation and cytokine production by
Kupffer cells. Thus, it was hypothesized that acute eth-
anol increases CD14 expression through a mechanism
dependent upon oxidant production. This hypothesis
was tested by overexpression of superoxide dismutase
via recombinant adenovirus. Mice were infected with
adenovirus (3  109 plaque-forming units, intrave-
nously) containing either Cu,Zn superoxide dismutase
(Ad.SOD1) or -galactosidase (Ad.lacZ), which caused
significant expression of Cu,Zn-SOD in hepatocytes and
Kupffer cells. Three days post-infection, mice were
given saline or ethanol (5 g/kg, intragastrically). A sig-
nificant increase in CD14 mRNA was observed 3 h after
ethanol, and this increase was almost completely
blocked in mice overexpressing Cu,Zn-SOD. Addition-
ally, overexpression of SOD also blunted ethanol-in-
duced activation of redox-sensitive transcription fac-
tors NFB and AP-1 and production of cytokines.
However, only inhibition of AP-1 with dominant-nega-
tive TAK1 but not NFB by dominant-negative IB sig-
nificantly blunted ethanol-induced increases in CD14,
suggesting that AP-1 is important for CD14 transcrip-
tional regulation. It is also shown here that NADPH
oxidase is important in the increase in CD14 due to
ethanol. Moreover, these data suggest that acute etha-
nol causes sensitization to endotoxin through mecha-
nisms dependent upon oxidative stress.
Ethanol is known to cause sensitization to endotoxin (lipopo-
lysaccharide (LPS)),1 yet the mechanisms responsible for this
observation are not clearly understood. It is known that etha-
nol modulates both the expression and activity of several in-
tracellular signaling molecules and transcription factors in
monocytes and Kupffer cells, the resident hepatic macro-
phages. For example, acute ethanol increases expression and
activity of the interleukin-1 receptor-associated kinase in
mouse Kupffer cells (IRAK) (1). Recently, the signaling path-
ways involved in CD14 receptor activation have been described
(2, 3). Because CD14 is not a transmembrane-spanning recep-
tor, it couples with the toll-like receptor 4 (Tlr-4) and initiates
intracellular signaling cascades (2, 3). Specifically, the Tlr-4
protein activates the IRAK, which in turn activates the NFB
signaling cascade including NIK, IKK, IB, and NFB (4–6).
Moreover, activation of Kupffer cell by LPS leads to an increase
in oxidant (i.e. superoxide and nitric oxide) through NADPH
oxidase and nitric-oxide synthase, respectively. Interestingly,
oxidant production is required for full activation of LPS-in-
duced NFB (7), suggesting that oxidants are involved in the
signaling mechanisms. It was recently demonstrated that over-
expression of antioxidant superoxide dismutase in Kupffer cells
blunts LPS-induced NFB activation and TNF production in
Kupffer cells in vitro (8).
It has been reported that ethanol also alters the subunit
composition of inflammatory transcription factor NFB by in-
ducing the formation of p50 homodimerization of NFB (9).
Independent studies have shown that both IRAK and tran-
scription factors NFB and AP-1 are redox-sensitive (10). Thus,
it is conceivable that oxidant production affects key signaling
molecules and transcription factors and that these alterations
are involved in sensitization to LPS caused by acute ethanol.
Enomoto et al. (11) have described the phenomena whereby
ethanol alters the response of Kupffer cells, the resident he-
patic macrophages, to a subsequent insult by LPS in vivo. It
was also shown that pretreatment of animals with nonabsorb-
able antibiotics completely prevents tolerance and sensitiza-
tion caused by ethanol, suggesting the mechanism involves
gut-derived LPS and activation of Kupffer cells (12). It was also
reported that an increase in CD14 expression correlated with
sensitization. Thus, it is hypothesized that Kupffer cells are
activated initially by LPS to produce oxidants via NADPH
oxidase, which activates redox-sensitive transcription factors
leading to an increase in cytokine production and CD14 expres-
sion. This hypothesis was tested by overexpressing antioxidant
Cu,Zn superoxide dismutase (SOD) in liver using recombinant
adenovirus. It is also important to note that adenovirus trans-
duces both hepatocytes and Kupffer cells in vivo (8). Here, it is
reported that ethanol increases both NFB and AP-1 activity
as well as cytokine production, all of which are blunted by SOD
overexpression. Ethanol-induced increases in CD14 mRNA are
blunted significantly by SOD overexpression, consistent with
the hypothesis that ethanol-induced sensitization is mediated
in part by an increase in CD14, which is dependent upon
oxidant production. Finally, it is demonstrated that inhibition
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of AP-1 with dominant-negative TAK1, an up-stream kinase for
c-jun, blunts ethanol-induced up-regulation of CD14. These
data clearly support the hypothesis that ethanol exposure re-
sults in the up-regulation of CD14 through oxidant-dependent
activation of AP-1.
MATERIALS AND METHODS
Animals and Treatment—Male C57Bl/6 mice (18–22 g, The Jackson
Laboratory) were used for these experiments except for studies evalu-
ating the role of NADPH oxidase and TNF in CD14 mRNA regulation.
For those studies, mice deficient in p47phox, a required regulatory sub-
unit of NADPH oxidase, and mice deficient in TNF were used. The
p47phox knockout mice were originally obtained from Dr. Steve Holland
(13). The TNF knockout mice were purchased as breeding pairs (The
Jackson Laboratory), and colonies have been maintained within IACUC
(Institutional Animal Care and Use Committee)-approved facilities and
guidelines. C57Bl/6 were infected with adenovirus (1  109 plaque-
forming units/animal, intravenously) 3 days prior to receiving either
saline or ethanol (5 g/kg, intragastrically).
Adenoviral Synthesis and Preparation—Recombinant adenovirus
containing the transgene for either Cu,Zn-SOD (Ad.SOD1) or -galac-
tosidase (Ad.lacZ) was prepared as described elsewhere (14, 15).
Briefly, the plasmid shuttle vector pAd5.CMV.lacZ was constructed by
standard cloning protocols as described by Sambrook et al. (16). The
adenoviral shuttle plasmid was transfected into the permissive HEK-
293 host cell line to generate recombinant Ad.lacZ adenovirus. Recom-
binant adenovirus containing the transgene for human Cu,Zn superox-
ide dismutase (Ad.SOD1) was the kind gift of Dr. John Engelhardt
(University of Iowa). Preparation of adenovirus containing the trans-
gene for hemagglutinin-tagged IB super-repressor (Ad.IB) has been
described previously (17). The IB super-repressor is a dominant-
negative protein that contains Ser323 Ala and Ser363 Ala mutations,
which inhibit phosphorylation and prevent NFB dissociation and
translocation into the nucleus. Recombinant adenoviruses containing
dominant-negative TAK, an inhibitor of LPS-induced AP-1 activation
(18), was provided by Dr. Richard Rippe (University of North Carolina).
The virus isolates were plaque-purified and propagated in HEK-293
cells, isolated, concentrated, and titered by plaque assay. Purified re-
combinant adenovirus (1  109 plaque-forming units) was suspended in
normal saline and injected into animals via the tail vein.
Liver Cell Isolation—Kupffer cells and hepatocytes were isolated
from naive Sprague-Dawley rats (250–300 g) or rats infected with
Ad.lacZ (1  109 pfu) 3 days earlier. Briefly, livers were isolated fol-
lowing pentobarbital anesthesia (60 mg/kg, intraperitoneally) and per-
fused via the portal vein for 10 min with Krebs-Ringer-HEPES buffer
containing 115 mM NaCl, 5 mM KCl, 1 mM KH2PO4, 25 mM HEPES, 1
mM CaCl2, and 0.016% collagenase (pH 7.4) followed by 10 min of
perfusion with calcium-free buffer containing 0.5 mM EGTA. Liver cells
were dispersed by gentle shaking in phosphate-buffered saline (pH 7.4,
4 °C), and the nonparenchymal cell fraction was separated from paren-
chymal cells by centrifugation through Percoll gradients based on a
method developed by Smedsrod and Pertoft (19).
Western Blot Analysis—Either whole liver or isolated hepatocytes
and Kupffer cells were homogenized, and samples (30 g) were resolved
by electrophoresis using 12% SDS-PAGE. Proteins were blotted with
either anti--galactosidase antibody (Roche Molecular Biochemicals) or
anti- Cu,Zn-SOD antibody (Oxis, Portland, OR), followed by horserad-
ish peroxidase-conjugated secondary antibody. The anti-SOD antibody
is cross-reactive with both endogenous rat Cu,Zn-SOD and the human
recombinant SOD. Protein was visualized by radiography using ECL
Western detection reagent (Amersham Biosciences).
Immunohistochemical Staining for CD14—Formalin-fixed, paraffin-
embedded sections (6 m) were mounted on glass slides. Sections were
deparaffinized, rehydrated, and then stained with mouse anti-CD14
primary antibody (Santa Cruz Biotechnology) for 30 min. The immu-
nostaining was visualized using the DAKO immunostaining kit. Slides
were counterstained with hematoxylin. Primary antibody dilutions
were 1:500 in phosphate-buffered saline containing 1% Tween 20.
Electomobility Shift Assay—For studies in whole liver, nuclear ex-
tracts were isolated as described by Dignam et al. (20) with minor
modifications (21). Binding conditions for NFB and AP-1 were char-
acterized and EMSA was performed as described elsewhere (22, 23).
Briefly, nuclear extracts (20 g) from liver tissue were preincubated
with 1 g of poly(dI-dC), 20 g bovine serum albumin (Amersham
Biosciences) and 2 l of a 32P-labeled DNA probe (10,000 cpm/l)
containing 1 ng of double-stranded oligonucleotide in a total volume of
20 l. Mixtures were incubated FOR 20 min on ice and resolved on 5%
polyacrylamide (29:1 cross-linking) and 0.4 TBE (Tris borate-EDTA)
gels. After electrophoresis, gels were dried and exposed to X-Omat LS
Kodak film. The intensity of NFB and NFB binding was quantitated
by scanning autoradiograms with GelScan XL (Amersham Biosciences)
and is expressed as arbitrary densitometric units.
RNase Protection Assay—Total RNA was isolated from liver tissue
using RNA-STAT 60 (Tel-Test, Friendswood, TX). RNase protection
assays for cytokine expression were performed using the RiboQuant
multiprobe assay system (Pharmingen). Briefly, [32P] RNA probes were
transcribed with T7 polymerase using the multiprobe template set
mCK-3 (Pharmingen). For CD14, a cDNA fragment amplified by re-
verse transcriptase PCR from mouse macrophage cDNA library was
subcloned into pCR-Topo (Stratagene, Cedar Creek, TX) by standard
cloning procedures. Prior to translation of the RNA probe, the pCR
plasmid containing the CD14 insert was linearized by HindIII restric-
tion digest. The RNA probe was generated with T7 polymerase using
the transcription assay described above. RNA (20 g) was hybridized
with 4  105 cpm of probe overnight at 56 °C. Samples were then
digested with RNase followed by proteinase K treatment, phenol:chlo-
roform extraction, and ethanol precipitation. Samples were resolved on
a 5% acrylamide-bisacrylamide (19:1) urea gel. After drying, the gel was
visualized by autoradiography.
RESULTS
The Overexpression of SOD in Nonparenchymal and Paren-
chymal Cells—To evaluate gene transfer of SOD in these stud-
ies, whole liver extracts were evaluated by Western blot using
antibodies against the human isoform of Cu,Zn-SOD (Fig. 1A).
In the livers of animals 3 days after Ad.lacZ infection, low
levels of human Cu,Zn-SOD were detected, which was most
likely caused by cross-reactivity with the mouse isoform. In
Ad.SOD1-infected mice, however, significant Cu,Zn-SOD ex-
pression was observed.
It was demonstrated that recombinant adenovirus could
transduce both hepatocytes and Kupffer cells in vivo (8). Thus,
FIG. 1. Expression of SOD in hepatocytes and Kupffer cells.
Mice were infected with either Ad.lacZ or Ad.SOD1 (1  109 pfu). Three
days after the injection, livers were harvested. A, whole liver extracts
were separated by 12% SDS-PAGE, and SOD expression was deter-
mined by Western blot (WB) analysis using anti-Cu,Zn-SOD antibody.
Each lane represents extract from individual mice. B, hepatocytes and
Kupffer cells were isolated from mice infected with either Ad.lacZ or
Ad.SOD1 as described under “Materials and Methods.” Extracts were
separated by 16% SDS-PAGE followed by immunoblotting with a mono-
clonal antibody against -galactosidase or Cu,Zn-SOD. Lysates from
human embryonic kidney (HEK-293) cells infected with Ad.lacZ and
Ad-SOD1 were used as positive controls.
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experiments were performed to determine whether SOD was
overexpressed in each cell type following Ad.SOD1 infection in
mice. Mice were infected with either Ad.lacZ or Ad.SOD1 as
described above, and Kupffer cells and hepatocytes were iso-
lated 3 days after infection as described under “Materials and
Methods.” Lysates from each cell type were separated by SDS-
PAGE and immunoblotted for either Cu,Zn-SOD or -galacto-
sidase (Fig. 1B). -Galactosidase was detected in hepatocytes
from Ad.lacZ-infected animals but not in hepatocytes from
Ad.SOD1-infected mice. Similarly, -galactosidase expression
was observed in Kupffer cells from Ad.lacZ-infected animals
but not in those from Ad.SOD1-infected mice. As expected,
Cu,Zn-SOD expression in hepatocytes was significantly in-
creased in mice infected with Ad.SOD1 compared with mice
infected with Ad.lacZ. Kupffer cells from Ad.lacZ-infected mice
expressed very little Cu,Zn-SOD. However, Cu,Zn-SOD expres-
sion was significantly increased in Kupffer cells from mice
infected with Ad.SOD1, confirming that Ad.SOD1 transduces
both hepatocytes and Kupffer cell in vivo, resulting in overex-
pression of SOD in each cell type.
Ethanol-induced Sensitization to LPS in Mouse Liver Is
Blunted by Overexpression of SOD—It is known that ethanol
enhances the response of mice to LPS administration. The
hypothesis that acute oxidative stress plays a role in the mech-
anisms of sensitization was tested here. First, C57Bl/6 mice
were given either saline or ethanol (5 g/kg, intragastrically)
followed by LPS (2.5 mg/kg, intravenously) 24 h later. Serum
alanine transaminase (ALT) levels were measured at 0, 1, 2, 4,
and 8 h after LPS administration (Fig. 2A). As expected, serum
ALT levels were elevated in saline-pretreated animals at 8 h
after LPS at 110  12 units/ml. However, in ethanol-pretreated
mice, the increase in serum ALT levels 8 h after LPS was
significantly potentiated by nearly 80% (186  12 units/ml, p 
0.05, Repeated measures ANOVA) mice. These data support
the hypothesis that ethanol induces sensitization to LPS,
which is consistent with numerous reports.
Next, animals were infected with recombinant adenovirus
(1  109 pfu/animal, intravenously) containing either Cu,Zn-
superoxide dismutase (Ad.SOD1) or -galactosidase (Ad.lacZ).
Three days after infection, when transgene expression is opti-
mal, animals were given either saline or ethanol (5 g/kg, intra-
gastrically), followed 24 h later by LPS (2.5 g/kg, intravenously)
or vehicle alone. The increase in serum ALT levels caused by
LPS alone was slightly blunted in Ad.SOD1-infected mice but
was not significantly different after 8 h compared with levels in
Ad.lacZ-infected animals (Fig. 2B). As expected, ethanol pre-
treatment of Ad.lacZ-infected animals given LPS resulted in a
significant increase in serum ALT release over Ad.lacZ-in-
fected animals pretreated with saline. Importantly, under
these conditions, ethanol alone in both Ad.lacZ- and Ad.SOD1-
infected animals did not cause a significant increase in ALT
release. However, in animals infected with Ad.SOD1, ethanol
pretreatment had no effect on LPS-induced increase in serum
ALT levels. These data strongly support the hypothesis that
oxidative stress participates in the mechanisms of sensitization
to LPS induced by ethanol in mouse liver.
Overexpression of SOD Blunts Acute Ethanol-induced Redox-
sensitive Transcription Factor Activation—To understand how
oxidants participate in the mechanisms of ethanol-induced sen-
sitization to LPS, the hypothesis that oxidants are involved in
activation of the redox-sensitive transcription factors NFB and
AP-1 following acute ethanol was tested. First, control mice were
given ethanol (5 g/kg, intragastrically), liver nuclear extracts
were isolated 0, 1, 3, and 6 h later, and the DNA binding activity
of both NFB and AP-1 was evaluated by EMSA (Fig. 3). Peak
NF DNA binding activity was observed 3 h after ethanol
exposure (Fig. 3A). Using nuclear extracts isolated 3 h after
ethanol exposure, competition and supershift assays were per-
formed to validate the specificity of NFB DNA binding. The
addition of unlabeled probe completely blocked DNA binding in
extracts from ethanol-treated mice. Moreover, the addition of
antibodies against mouse p50 and p65 subunits of NFB caused
retardation in NFB gel shift mobility, confirming the formation
of active NFB induced by ethanol exposure. Similar studies
were performed to evaluate the activation of AP-1 following acute
ethanol. The DNA binding activity of AP-1 also peaked at 3 h
after ethanol (Fig. 3B). The specificity of AP-1 DNA binding was
also determined by competition and supershift assays using an-
tibodies against both c-Fos and c-Jun.
To test the hypothesis that overexpression of Cu,Zn-SOD
would blunt acute ethanol-induced NFB and AP-1 activation,
mice were infected with recombinant Ad.lacZ (1  109 pfu/
FIG. 2. Overexpression of SOD blunts acute ethanol-induced
sensitization to LPS. A, mice (22–25 g, C57Bl/6) were given LPS (2.5
mg/kg) 21 h after receiving ethanol (5 g/kg, intragastrically) or saline.
Serum was collected at intervals of up to 8 h after LPS, and serum
transaminase levels were measured as described under “Materials and
Methods.” B, mice (22–25 g, C57Bl/6) were infected with recombinant
adenovirus (1  109 pfu/animal) containing either Cu,Zn-SOD or -ga-
lactosidase. Three days after infection, mice were given ethanol (5 g/kg,
intragastrically) or saline followed by LPS (2.5 mg/kg) after 21 h. Serum
was collected at intervals of up to 8 h after LPS, and serum transami-
nase levels were measured as described under “Materials and
Methods.”
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animal) or Ad.SOD1 as described above. Three days after in-
fection, mice were given 5 g/kg ethanol, and nuclear extracts
were isolated from liver 3 h later. Ethanol caused a significant
increase in NFB activity in Ad.lacZ-infected mice. Impor-
tantly, ethanol-induced NFB activation was markedly
blunted in mice infected with Ad.SOD1 (Fig. 3C). In animals
infected with Ad.lacZ, ethanol induced a significant increase in
AP-1 activity, which was not observed in animals infected with
Ad.SOD1 (Fig. 3D). These data strongly support the hypothesis
that oxidant generation caused by exposure to acute ethanol is
important for activation of redox-sensitive transcription factor
AP-1. Moreover, these data suggest that activation of NFB
and AP-1 may be important in the sensitization to LPS caused
by acute ethanol exposure.
Cytokine Production Caused by Acute Ethanol Exposure Is
Blunted by SOD—NFB and AP-1 are known transcription
factors that regulate the expression of several inflammatory
cytokines. Thus, mRNA levels of cytokines were measured in
livers of Ad.lacZ- and Ad.SOD1-infected mice following admin-
istration of either saline or ethanol (Fig. 4). Consistent with
transcription factor activation, mRNA levels for TNF were
significantly elevated in Ad.lacZ-infected animals following
ethanol injection. In Ad.SOD1-infected mice, the ethanol-in-
duced increase in TNF mRNA was blunted by 70%. Simi-
larly, ethanol caused an increase in interleukin-6 mRNA levels,
which was nearly completely blocked in Ad.SOD1-infected
mice. These changes in mRNA, quantified by phosphorimaging,
clearly demonstrate that oxidants are involved in the acute
ethanol-induced increase in cytokine production.
To verify these findings, serum cytokine levels were meas-
ured in mice following ethanol exposure. In animals infected
with Ad.lacZ, a peak increase in serum TNF levels was
observed 6 h after ethanol administration. Ethanol caused a
significant increase in TNF from basal levels of 28.1  4.3
pg/ml to 46.7  7.4 pg/ml (p  0.05, two-way ANOVA, Tukey’s
post hoc analysis). This increase in serum TNF was blunted to
29.4  6.3 pg/ml in mice infected with Ad.SOD1. These data
correlate with the ethanol-induced changes in TNF mRNA lev-
els in mice infected with Ad.lacZ and Ad.SOD. Surprisingly,
interleukin-1 or interleukin-6 was not detected in serum follow-
ing ethanol exposure in either Ad.lacZ- or Ad.SOD1-infected
mice. Perhaps this is related to changes in localized expression of
these cytokines, which may not alter serum levels.
Acute Ethanol Increases CD14 Expression—Recently it was
demonstrated that chronic ethanol-fed animals exhibited high
levels of CD14 expression on Kupffer cells (12, 25). The hypoth-
esis is that ethanol exposure causes an up-regulation of CD14,
which “primes” Kupffer cells to LPS causing an elevated in-
flammatory response. Moreover, promoter elements for the
CD14 gene have been shown to contain several AP-1 consensus
binding sites (26, 27). Thus, the hypothesis that acute ethanol
increased the expression of CD14 in whole liver was tested.
Animals were given ethanol (5 g/kg, intragastrically) and sac-
rificed after 0, 1, 3, 12, and 21 h. CD14 mRNA, measured by
RNase protection assay, was elevated significantly at 3 h after
FIG. 3. Acute ethanol-induced redox-sensitive transcription
factor activation is blunted by SOD. A, mice were given ethanol (5
g/kg, intragastrically) and sacrificed after 0, 1, 3, and 6 h. Nuclear
extracts (20 g) prepared from whole liver were used to evaluate NFB
DNA binding activity by EMSA as described under “Materials and
Methods.” Using nuclear extract isolated from mice 3 h after ethanol
exposure, NFB competition assay using 100-fold excess unlabeled oligo
(comp), and supershift assays using 4 l of p50 and p65 antibodies
(Santa Cruz Biotechnology) were performed. B, AP-1 DNA binding
activity was determined by EMSA using nuclear extract as described
above. Competition was performed using excess unlabeled AP-1 oligo,
and supershifts were done using 4 l of antibody against either c-fos or
c-jun (Santa Cruz Biotechnology). Arrows refer to specific DNA binding;
ss, supershifted DNA-binding complex. C, mice were infected with re-
combinant adenovirus (1  109 pfu/animal) containing either -galac-
tosidase (Ad.lacZ) or Cu,Zn-SOD (Ad.SOD1). Three days after infection,
mice received ethanol (5 g/kg, intragastrically) or saline (Con) and
sacrificed 3 h later. NFB was measured by EMSA as described under
“Materials and Methods.” D, AP-1 activity was measured 3 h after
ethanol administration in mice infected with either Ad.lacZ or
Ad.SOD1. Gels shown are representative of three individual
experiments.
FIG. 4. Increase in cytokine mRNAs after acute ethanol admin-
istration. A, whole liver RNA was isolated from animals infected with
Ad.lacZ or Ad.SOD1 (1  109 pfu/animal) 3 h after ethanol (5 g/kg,
intragastrically) or saline administration. Cytokine expression was
measured by RNase protection assay as described under “Materials and
Methods.” B, image analysis was performed on an RNase protection
assay from the experiments described above using an ImageQuant
PhosphorImager. Data are expressed as means  S.E. and are repre-
sentative of three experiments in each group. (*, p  0.05, two-way
ANOVA, Tukey’s post hoc analysis).
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ethanol administration (Fig. 5A), supporting the hypothesis
that ethanol increases CD14 expression in vivo.
To test the hypothesis that oxidants were involved in ethanol-
induced up-regulation of CD14, mice were infected with
Ad.SOD1 (1  109 pfu/animal) or Ad.lacZ 3 days prior to ethanol
(5 g/kg, intragastrically) or saline treatment, and CD14 mRNA
was measured 3 h later. Compared with saline, ethanol caused a
significant increase in CD14 mRNA in Ad.lacZ-infected animals.
However, the increase in CD14 induced by ethanol was dramat-
ically blunted in animals infected with Ad.SOD1 (Fig. 5B). These
data strongly support the hypothesis that oxidants are involved
in acute ethanol-induced increases in CD14 levels. The strong
correlation between the inhibition of redox-sensitive transcrip-
tion factors and CD14 up-regulation suggests that CD14 expres-
sion may be regulated by NFB and/or AP-1.
Because it has been reported that CD14 can be expressed on
hepatocytes in addition to Kupffer cells, it was important to
determine the location of CD14 expression following acute eth-
anol exposure. To test the hypothesis that ethanol caused an
up-regulation of CD14 primarily on Kupffer cells, liver sections
from mice infected with either Ad.lacZ or Ad.SOD1 and given
either saline or ethanol were stained immunohistochemically
for CD14 (Fig. 6). Compared with results in saline-treated
mice, a significant increase in CD14 detection was observed
24 h after ethanol administration. CD14 expression was in-
creased predominantly in sinusoidal cells (i.e. Kupffer cells).
Ethanol-induced CD14 expression was not significantly in-
creased over basal levels of expression in mice infected with
Ad.SOD1. This is an important finding confirming that an
increase in CD14 mRNA translates into increased protein ex-
pression and that ethanol-induced expression is most likely
limited to Kupffer cells within the liver.
Inhibition of AP-1 Blunts Ethanol-induced Up-regulation of
CD14—Because AP-1 regulatory sites are present in the pro-
moter region of CD14 (27), it was hypothesized that AP-1
regulates CD14 expression following acute ethanol administra-
tion. To test this hypothesis, animals were infected with an
adenovirus (1  109 pfu/animal, intravenously) containing the
transgene for either -galactosidase, dominant-negative IB,
an inhibitor of NFB, or dominant-negative TAK1 (Ad.TAK),
an up-stream activation kinase for AP-1 (18). Three days after
infection, animals were given 5 g/kg ethanol as above and
sacrificed 3 h later, and CD14 mRNA levels were measured by
RNase protection assay (Fig. 7). As expected, in Ad.lacZ-in-
fected animals, ethanol caused a significant increase in CD14
mRNA compared with animals given saline. Overexpression of
dominant-negative IB, a specific inhibitor of NFB, had no
effect on ethanol-induced up-regulation of CD14, despite a
clear inhibition of NFB activation in vivo (data not shown).
However, the increase in CD14 mRNA levels following ethanol
was dramatically blunted in animals infected with Ad.TAK,
strongly supporting the hypothesis that AP-1 activation is in-
volved in the up-regulation of CD14 under these conditions.
Also, overexpression of dominant-negative TAK significantly
blunted ethanol-induced activation of AP-1 DNA binding com-
pared with controls (data not shown).
NADPH Oxidase Is Necessary for Acute Ethanol-induced In-
creases in CD14—Because oxidants are involved in acute eth-
anol-induced CD14 expression in vivo, and CD14 is primarily
expressed on Kupffer cells, it is hypothesized that NADPH oxi-
dase, the primary source of oxidants in Kupffer cells, is important
in the mechanism. Thus, ethanol (5 g/kg, intragastrically) or
saline was given to either wild-type or NADPH oxidase-deficient
mice (p47phox/), and CD14 expression was measured 3 h later.
As expected, in wild-type mice, administration of ethanol, as
compared with saline, caused a significant increase in CD14
mRNA (Fig. 8A). However, ethanol-induced CD14 expression
was blunted by 75% in NADPH oxidase-deficient mice. These
data strongly suggest that NADPH oxidase is central to oxidant
production following acute ethanol and that it is involved in the
up-regulation of CD14, most likely through NFB and AP-1
transcription factors.
FIG. 5. Ethanol-induced CD14 expression is blunted by SOD. A,
mice were given ethanol (5 g/kg, intragastrically) and sacrificed at 0, 1,
3, 12, and 21 h after ethanol exposure. CD14 mRNA was then measured
by RNase protection assay. B, mice, treated as described in the legend
for Fig. 4, were sacrificed at 3 h after ethanol or saline exposure. CD14
mRNA levels were measured by RNase protection assay as described
under “Materials and Methods.” These data are representative of three
individual experiments.
FIG. 6. Localization of CD14 expression. Mice (22–25 g, C57Bl/6)
were infected with recombinant adenovirus (1  109 pfu/animal) con-
taining either -galactosidase (A and C) or Cu,Zn-SOD (B and D). Three
days after infection, mice were given saline (A and B) or ethanol (C and
D) (5 g/kg, intragastrically). 24 h later, mice were sacrificed and livers
were harvested. Liver sections were stained immunohistochemically for
CD14 using antibodies against mouse CD14 (Santa Cruz Biotechnolo-
gy). Data are representative of four individual experiments.
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TNF Signaling Is Not Required for Ethanol-induced In-
creases in CD14—Because acute ethanol causes TNF produc-
tion and also oxidative stress, we hypothesized that TNF
mediates AP-1 activation and up-regulation of CD14. To test
this hypothesis, mice deficient in TNF (TNF/) and wild-
type control mice were given either saline or ethanol (5 g/kg,
intragastrically). Three hours later, the mice were sacrificed,
and the level of CD14 mRNA was measured by RNase protec-
tion assay (Fig. 8B). In the wild-type controls, ethanol induced
a significant increase in CD14 expression compared with wild-
type mice receiving only saline. Similarly, ethanol caused a
significant increase in CD14 mRNA in TNF/ mice. Impor-
tantly, the increase in CD14 mRNA due to ethanol was not
different between wild-type and TNF/ mice, suggesting
that TNF signaling is not required for the increase in CD14
expression under these conditions.
DISCUSSION
Role of CD14 in Ethanol-induced Liver Disease—A recently
described polymorphism in the human CD14 promoter region,
resulting in higher levels of CD14, is associated with an in-
crease in severity of alcoholic liver disease (28). These human
studies, along with several animal studies, strongly support
the involvement of CD14 in alcoholic liver disease and suggest
that CD14 is a risk factor for ethanol-induced pathology (29).
CD14, which is expressed largely on Kupffer cells in the liver,
is activated by circulating endotoxin that enters the liver via
the portal vein. CD14 is a membrane-associated receptor but
has no transmembrane-spanning region. Thus, it associates
with the toll-like receptor-4, which initiates intracellular sig-
naling. Although clearly defined signaling pathways have not
been identified, activation of CD14 results in the production of
superoxide free radicals and toxic cytokines, including TNF,
as well as a number of other inflammatory responses. Mice
deficient in CD14 are almost completely resistant to LPS-in-
duced liver injury at physiological levels (i.e. less than 10–50
pg/ml). Moreover, CD14-deficient mice do not exhibit any path-
ological changes due to chronic ethanol exposure compared
with wild-type mice. Together, these findings demonstrate the
importance of CD14 and endotoxin in ethanol-induced liver
injury. Activation of CD14 on Kupffer cells leads to the produc-
tion of superoxide and TNF, which are involved in the patho-
genesis of alcoholic liver disease.
Up-regulation of CD14 in Sensitization—We and others have
shown that CD14 levels are elevated in liver following chronic
exposure to ethanol (1, 24, 25). This increase correlates with
ethanol-induced liver injury. Thus, steady increases in CD14
expression because of ethanol exposure, resulting in increased
cytokine production, could exacerbate ethanol-induced injury.
These studies were done to understand the mechanisms in-
volved in CD14 up-regulation due to ethanol. It is shown here
that acute ethanol administration leads to a rapid increase in
CD14 expression in vivo. These data are consistent with the
FIG. 7. Inhibition of AP-1 blunts ethanol-induced CD14 up-
regulation. A, mice were infected with recombinant adenovirus (1 
109 pfu/animal) containing -galactosidase (Ad.lacZ), dominant-nega-
tive IB super-repressor (Ad.IB), or dominant-negative TAK
(Ad.TAK). Three days after infection, mice received ethanol (5 g/kg,
intragastrically) or saline and were sacrificed 3 h later. CD14 mRNA
was evaluated by RNase protection assay as described under “Materials
and Methods.” B, image analysis was performed using an ImageQuant
PhosphorImager. Data are expressed as means  S.E. and are repre-
sentative of three experiments in each group. (*, p  0.05, two-way
ANOVA, Tukey’s post hoc analysis).
FIG. 8. NADPH oxidase, but not TNF, is required for ethanol-
induced increase in CD14. Mice deficient in p47phox, a critical regu-
latory subunit of NADPH oxidase (p47phox/), TNF (TNF/), or
wild-type control mice were given ethanol (5 g/kg, intragastrically) or
saline, and CD14 mRNA was evaluated 3 h later by RNase protection
assay as described under “Materials and Methods.” Data are expressed
as means  S.E. and are representative of three experiments in each
group. (*, p  0.05, two-way ANOVA, Tukey’s post hoc analysis).
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observation that acute ethanol causes hypersensitivity to LPS,
a mechanism known as “priming” or “sensitization.” It is hy-
pothesized that ethanol activates signaling mechanisms that
result in the up-regulation of CD14 on Kupffer cells, which
sensitizes animals to subsequent challenge with LPS. Because
it is known that ethanol activates redox-sensitive transcription
factors NFB and AP-1 and induces a rapid increase in CD14
expression, it is hypothesized that oxidants activate either
NFB or AP-1 and increase the synthesis of CD14. Moreover, it
was hypothesized that overexpression of SOD would blunt the
increase in CD14 due to acute ethanol. In these experiments it
was clearly demonstrated that SOD blunted the priming effect
of ethanol in vivo (Fig. 2B). However, it is difficult to under-
stand whether SOD directly blunts the effects of ethanol on
priming or whether SOD blunts LPS signaling itself. Therefore,
studies were done to evaluate the role of oxidants in the prim-
ing effect of ethanol alone. Consistent with the hypothesis that
ethanol primes the liver, acute ethanol activates NFB and
AP-1 (Fig. 3). Acute ethanol also causes a transient increase in
cytokine production similar to the increase in CD14 expression
(Figs. 4 and 5). Thus, it was also hypothesized that activation
of transcription factors NFB and AP-1 played a role in the
up-regulation of CD14.
Activation of AP-1 and Up-regulation of CD14—To deter-
mine whether AP-1 was directly responsible for the up-regula-
tion of CD14, studies were done to inhibit AP-1 using domi-
nant-negative TAK expression via adenovirus. Inhibition of
AP-1, either indirectly by overexpression of SOD or directly by
dominant-negative TAK, blunted the increase in CD14 expres-
sion due to acute ethanol in addition to blunting AP-1 activa-
tion. TAK has been demonstrated to be an “up-stream” kinase
of AP-1, leading to its activation (18). These data are consistent
with the hypothesis that AP-1 is a critical transcription factor
involved in the up-regulation of CD14. This finding is consist-
ent with other reports demonstrating that the CD14 promoter
contains several AP-1-responsive elements (26). Overexpres-
sion of superoxide dismutase blunted ethanol-induced activa-
tion of NFB and AP-1 and up-regulation of CD14, suggesting
that these redox-sensitive transcription factors are involved in
the regulation of CD14. However, it is likely that AP-1 and not
NFB is actually involved because NFB regulatory elements
within the CD14 promoter have not been identified. Moreover,
inhibition of NFB using the dominant-negative IB super-
repressor, although blocking ethanol-induced NFB activation,
had no effect on the up-regulation of CD14 following acute
ethanol (Fig. 7). On the other hand, inhibition of AP-1 activa-
tion using dominant-negative TAK completely and signifi-
cantly blunted the increase in CD14 expression (Fig. 7).
It is hypothesized that TNF release by Kupffer cells in
response to acute ethanol activates the AP-1 pathway, leading
to an increase in CD14 expression. However, we demonstrate
here that the up-regulation of CD14 was not affected in mice
deficient in TNF (Fig. 8). These data suggest that TNF
signaling is not necessary for ethanol to up-regulate CD14.
This is an important point because it was shown that TNF is
required for long-term ethanol induced liver injury. Interest-
ingly, deletion of NADPH oxidase in p47phox mutant mice did
inhibit CD14 up-regulation due to ethanol, supporting the hy-
pothesis that NAPDH oxidase is an early source of oxidants due
to ethanol. This experiment was performed to identify the
potential source of oxidant production that contributed to AP-1
activation and CD14 expression. The p47phox subunit is most
likely a critical regulatory factor of NADPH oxidase, based on
a number studies. Therefore, these data suggest that NADPH
oxidase is important for oxidant production following acute
ethanol. However, with the expanding information about
NADPH oxidase genes, it is becoming clear that p47phox expres-
sion is not limited to macrophages, unlike the catalytic subunit
gp91phox of NADPH oxidase, which is predominantly expressed
on macrophages. The role of gp91phox in ethanol-induced oxi-
dative stress in liver is an important unresolved question.
In conclusion, ethanol induces oxidant production through
NADPH oxidase in Kupffer cells leading to the activation of
redox-sensitive transcription factors, which simultaneously up-
regulates cytokine expression and CD14 expression. It has
recently been shown that CD14 is necessary for ethanol-in-
duced liver injury in mice and that increased levels of CD14
correlate with severity of alcoholic liver disease in humans.
Thus, it is very likely that acute doses of ethanol cause an
increase in CD14 and that progressive increases in CD14 un-
derlie the mechanisms of pathology. As ethanol exposure in-
creases in CD14 expression, a hyper-responsiveness may lead
to a significant and sustained increase in oxidant and cytokine
production, which disposes the liver to greater injury. Although
CD14 is required for ethanol-induced liver injury, it is not clear
whether basal levels of CD14 are sufficient to mediate the
pathological effects of ethanol and endotoxin or whether the
increase in CD14 expression is required. This is an intriguing
question because it represents a potential target for therapy, to
inhibit the up-regulation of CD14 in vivo.
REFERENCES
1. Yamashina, S., Wheeler, M. D., Rusyn, I., Ikejima, K., Sato, N., and Thurman,
R. G. (2000) Biochem. Biophys. Res. Commun. 277, 686–690
2. Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., and Goyert, S. M.
(1988) J. Immunol. 141, 547–552
3. Yoshimura, A., Lien, E., Ingalls, R. R., Tuomanen, E., Dziarski, R., and
Golenbock, D. (1999) J. Immunol. 163, 1–5
4. Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., and Arditi, M.
(2001) J. Immunol. 167, 1609–1616
5. Faure, E., Equils, O., Sieling, P. A., Thomas, L., Zhang, F. X., Kirschning, C. J.,
Polentarutti, N., Muzio, M., and Arditi, M. (2000) J. Biol. Chem. 275,
11058–11063
6. Wang, Q., Dziarski, R., Kirschning, C. J., Muzio, M., and Gupta, D. (2001)
Infect. Immun. 69, 2270–2276
7. Li, N., and Karin, M. (1999) FASEB J. 13, 1137–1143
8. Wheeler, M. D., Yamashina, S., Froh, M., Rusyn, I., and Thurman, R. G. (2001)
J Leukocyte Biol. 69, 622–630
9. Mandrekar, P., Catalano, D., and Szabo, G. (1997) Alcohol Clin. Exp. Res. 21,
988–994
10. Tewes, F., Bol, G. F., and Brigelius-Flohe, R. (1997) Eur. J. Immunol. 27,
3015–3021
11. Enomoto, N., Ikejima, K., Bradford, B. U., Rivera, C. A., Kono, H., Brenner,
D. A., and Thurman, R. G. (1998) Gastroenterology 115, 443–451
12. Enomoto, N., Ikejima, K., Yamashina, S., Hirose, M., Shimizu, H., Kitamura,
T., Takei, Y., Sato, A. N., and Thurman, R. G. (2001) Alcohol Clin. Exp. Res.
25, 51S-54S
13. Jackson, S. H., Gallin, J. I., and Holland, S. M. (1995) J. Exp. Med. 182,
751–758
14. Rigby, P. W. (1983) J. Gen. Virol. 64, 255–266
15. Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M.,
Stier, L. E., Paakko, P. K., Gilardi, P., and Stratford-Perricaudet, L. D.
(1991) Science 252, 431–434
16. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A
Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY
17. Iimuro, Y., Nishiura, T., Hellerbrand, C., Behrns, K. E., Schoonhoven, R.,
Grisham, J. W., and Brenner, D. A. (1998) J. Clin. Invest. 101, 802–811
18. Lee, J., Mira-Arbibe, L., and Ulevitch, R. J. (2000) J. Leukocyte Biol. 68,
909–915
19. Smedsrod, B., and Pertoft, H. (1985) J. Leukocyte Biol. 38, 213–230
20. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Nucleic Acids Res. 11,
1475–1489
21. Rusyn, I., Tsukamoto, H., and Thurman, R. G. (1998) Carcinogenesis 19,
1217–1222
22. Zabel, U., Schreck, R., and Baeuerle, P. A. (1991) J. Biol. Chem. 266, 252–260
23. Baeuerle, P. A., and Baltimore, D. (1989) Genes Dev. 3, 1689–1698
24. Kishore, R., Hill, J. R., McMullen, M. R., Frenkel, J., and Nagy, L. E. (2002)
Am. J. Physiol. 282, G6–G15
25. Kono, H., Wheeler, M. D., Rusyn, I., Lin, M., Seabra, V., Rivera, C. A.,
Bradford, B. U., Forman, D. T., and Thurman, R. G. (2000) Am. J. Physiol.
278, G652–G661
26. Matsuura, K., Ishida, T., Setoguchi, M., Higuchi, Y., Akizuki, S., and
Yamamoto, S. (1992) J. Biol. Chem. 267, 21787–21794
27. Liu, S., Shapiro, R. A., Nie, S., Zhu, D., Vodovotz, Y., and Billiar, T. R. (2000)
Gene 250, 137–147
28. Jarvelainen, H. A., Orpana, A., Perola, M., Savolainen, V. T., Karhunen, P. J.,
and Lindros, K. O. (2001) Hepatology 33, 1148–1153
29. Yin, M., Bradford, B. U., Wheeler, M. D., Uesugi, T., Froh, M., Goyert, S. M.,
and Thurman, R. G. (2001) J. Immunol. 166, 4737–4742
Acute Ethanol Increases CD14 Expression 8441
